Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.96M | 8.66M | 6.93M | 9.40M | 7.39M |
| Depreciation & Amortization | -52.10K | -52.10K | -52.10K | 26.30K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.50M | 14.04M | 10.62M | 11.84M | 9.06M |
| Operating Income | -16.50M | -14.04M | -10.62M | -11.84M | -9.06M |
| Income Before Tax | -16.51M | -13.97M | -10.57M | -9.68M | -9.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.51 | -13.97 | -10.57 | -9.68 | -9.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.51M | -13.97M | -10.57M | -9.68M | -9.68M |
| EBIT | -16.50M | -14.04M | -10.62M | -11.84M | -9.06M |
| EBITDA | -5.30M | -8.83M | -10.59M | -8.26M | -5.28M |
| EPS Basic | -1.36 | -1.37 | -1.17 | -1.14 | -2.29 |
| Normalized Basic EPS | -0.85 | -0.86 | -0.73 | -0.69 | -1.41 |
| EPS Diluted | -1.78 | -1.79 | -1.17 | -1.14 | -2.29 |
| Normalized Diluted EPS | -0.85 | -0.86 | -0.73 | -0.69 | -1.41 |
| Average Basic Shares Outstanding | 47.40M | 41.29M | 37.12M | 33.89M | 26.39M |
| Average Diluted Shares Outstanding | 47.40M | 41.29M | 37.12M | 33.89M | 26.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |